Table 3 ROC analysis and multivariate analysis of MVI presence in the training cohort
From: Contrast-enhanced CT findings-based model to predict MVI in patients with hepatocellular carcinoma
Variables | Multivariate analysis | ROC analysis | |||
|---|---|---|---|---|---|
|  | β | OR | P-value | AUC | Cutoff |
Maximum diameter | 0.015 | 1.015 (1.006,1.025) | .002 | 0.639 (0.558,0.719) | 50 |
Tumor margin | 1.259 | 3.523 (1.806,6.873) |  < .001 | 0.632 (0.563,0.701) | NA |
Arterial peritumoral enhancement | NA | NA | .999 | NA | NA |
Tumor number | NA | NA | .081 | NA | NA |
Hemoglobin | NA | NA | .083 | NA | NA |
TBil | NA | NA | .581 | NA | NA |
DBil | 0.043 | 1.044 (1.012,1.076) | .007 | 0.567 (0.485,0.65) | 2.7 |
AFP | 0.001 | 1.001 (1.000,1.002) | .032 | 0.629 (0.547,0.711) | 360.7 |